Skip to main content
. 2014 Aug 7;20(29):9633–9652. doi: 10.3748/wjg.v20.i29.9633

Table 1.

Boceprevir and telaprevir response guided therapy and futility rules

End-point Boceprevir Telaprevir
RGT Non-cirrhotic treatment naïve patients, previously relapsers or partial responders Non-cirrhotic treatment naïve patients previously relapsers
HCV-RNA undetectable at weeks 8 and 24 HCV-RNA undetectable at weeks 4 and 24
Futility rules HCV-RNA > 100 IU/mL at week 12 HCV-RNA > 1000 IU/mL at weeks 4 and 12
HCV-RNA detectable at week 24 HCV-RNA detectable at week 24

HCV: Hepatitis C virus.